NCT00998660 RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR) Status COMPLETED Phase PHASE4
NCT00982709 The Effects of Treadmill Versus Agility Training in Parkinson's Disease Status COMPLETED Phase NA
NCT00976430 Autologous Mesenchymal Stem Cell Transplant for Parkinson's Disease Status TERMINATED Phase NA
NCT00974974 A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). Status COMPLETED Phase PHASE3
NCT00957918 Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa Therapy Status COMPLETED Phase PHASE1/PHASE2
NCT00957203 Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients Status COMPLETED Phase PHASE3
NCT00955526 Study of KW-6002 (Istradefylline) for the Treatment of Parkinson's Disease in Patients Taking Levodopa Status COMPLETED Phase PHASE3
NCT00955318 Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease Status COMPLETED Phase PHASE3
NCT00955045 A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy Status COMPLETED Phase PHASE2/PHASE3
NCT00955032 Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Apathy in Parkinson's Disease Status COMPLETED Phase NA
NCT00947037 Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study Status WITHDRAWN Phase PHASE2
NCT00943748 Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00936676 ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects Status COMPLETED Phase N/A
NCT00932581 Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties Status COMPLETED Phase N/A
NCT00921128 Convection-Enhanced Delivery to Study the Pathophysiology Underlying the Clinical Features of Parkinson s Disease Status WITHDRAWN Phase PHASE1
NCT00918177 An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease Status COMPLETED Phase PHASE2